Ledger.Open graph →
SEC Form D · filed July 21, 2020

Unum Therapeutics Inc

Offering
$104.4M
Sold
$104.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Matthew L. Ros · Cambridge, MADirectorKaren L. Ferrante · Cambridge, MADirectorCharles Wilson · Cambridge, MAExec · DirectorArlene L. Morris · Cambridge, MADirectorJessica L. Sachs · Cambridge, MAExecJohn L. Green · Cambridge, MAExecChris L. Cain · Cambridge, MADirectorPeter L. Harwin · Cambridge, MADirectorTracey E. Griffin · Boca Raton, FLDirectorJames D. Devries · Boca Raton, FLExecEric L. Press · Boca Raton, FLDirectorDavid Rossini · Denver, COExec · DirectorMatthew H. Nord · Boca Raton, FLDirectorMarc S. Jones · Boca Raton, FLExecSamuel Landenwitsch · Denver, CODirectorReed B. Rayman · Boca Raton, FLDirectorUpper90 Partners Equity SPV GP III LLC · New York, NYDirectorRafael Colorado · Dallas, TXExecKimberly L. Grimm · Menomonee Falls, WIDirectorGlenn Harrison · Nashville, TNDirectorPaul Del Vecchio · Portland, ORDirectorJosh Bean · Portland, ORExec · DirectorShobi Dahl · Portland, ORDirectorPancham Gupta · Jericho, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗